Goldman Sachs analyst David Roman upgraded Medtronic, Inc. (NYSE: MDT) from Sell to Neutral with a price target of $111.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE